Major malaria study leads WHO to revise treatment guidelines

Major malaria study leads WHO to revise treatment guidelines
The Chinese herb qinghao (Artemisia annua), which is processed to make the drug artesunate. Credit: tonrulkens on Flickr.

The results of the largest ever clinical trial among patients hospitalised with severe malaria - the Wellcome Trust-funded AQUAMAT study - have led the World Health Organisation (WHO) to revise its guidelines for the treatment of the disease in African children.

AQUAMAT - the 'African quinine versus artesunate malaria trial' - involved researchers across Africa, working in collaboration with scientists in Thailand and the UK. The randomised, controlled trial enrolled 5425 children hospitalised with severe malaria across nine African countries. It showed a 22.5 per cent reduction in mortality among patients treated with artesunate compared to those given the standard treatment of quinine.

In line with these findings, the WHO has now changed its treatment guidelines to recommend parenteral artesunate as first-line treatment in the management of severe malaria in African children. The disease remains a major killer, with these patients accounting for 90 per cent of the one million deaths that occur annually. Changing the first-line treatment from quinine to artesunate has the potential to save hundreds of thousands of children's lives across each year.

Professor Nick White of Oxford University, who led the study, says: "The AQUAMAT trial is a very important step in reducing preventable childhood death in the tropics. It is very gratifying for the many investigators to see their research findings being turned into a globally influential policy. If implemented this will save hundreds of thousands of young lives."

The AQUAMAT team has also been shortlisted as one of the three finalists in the category of Research Paper of the Year in the prestigious British Medical Journal Awards.

Dr Jimmy Whitworth, Head of International Activities at the Wellcome Trust, adds: "This is clearly an immensely important piece of work by Nick White and colleagues and an excellent example of how multicentre research can be conducted across many countries and even continents. This has provided the rigorous evidence necessary to inform the WHO's revised guidelines and we hope this will have a dramatic effect on the lives of children across the African continent."

add to favorites email to friend print save as pdf

Related Stories

Rectal artemisinins rapidly eliminate malarial parasites

Mar 28, 2008

Artemisinin-based suppositories can help ‘buy time’ for malaria patients who face a delay in accessing effective, injectable antimalarials, according to research published in the online open access journal BMC Infectious Di ...

Recommended for you

US looking past Ebola to prepare for next outbreak

9 hours ago

The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, U.S. public health officials are girding for the next health disaster.

Can robots help stop the Ebola outbreak?

18 hours ago

The US military has enlisted a new germ-killing weapon in the fight against Ebola—a four-wheeled robot that can disinfect a room in minutes with pulses of ultraviolet light.

New bird flu case in Germany

18 hours ago

A worrying new strain of bird flu has been observed for the first time in a wild bird in northern Germany, the agriculture ministry said Saturday.

Mali announces new Ebola case

Nov 22, 2014

Mali announced Saturday a new case of Ebola in a man who is fighting for his life in an intensive care unit in the capital Bamako.

Plague outbreak kills 40 in Madagascar: WHO

Nov 22, 2014

An outbreak of plague has killed 40 people in Madagascar, the World Health Organization said, warning that the disease could spread rapidly in the country's densely populated capital Antananarivo.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.